BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scaffaro LA, Kruel CD, Stella SF, Gravina GL, Machado Filho G, Borges de Almeida CP, Pinto LC, Alvares-da-Silva MR, Kruel CR. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres. Biomed Res Int 2015;2015:435120. [PMID: 26413523 DOI: 10.1155/2015/435120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Nakasumi K, Sunahara H, Igari K, Itoh H, Itamoto K, Yamamoto N, Ishikawa T, Takami T, Sakaida I, Taura Y, Tani K. Effect of transcatheter arterial embolisation in normal canine liver using trisacryl gelatine microspheres (Embosphere). Res Vet Sci 2020;129:174-7. [PMID: 32036125 DOI: 10.1016/j.rvsc.2020.01.018] [Reference Citation Analysis]
2 Tanaka Y, Hashimoto T, Watanabe D, Okada H, Kato D, Aoyagi S, Akimoto J, Kohno M. Post-embolization neurological syndrome after embolization for intracranial and skull base tumors: transient exacerbation of neurological symptoms with inflammatory responses. Neuroradiology 2018;60:843-51. [DOI: 10.1007/s00234-018-2047-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Gruber-Rouh T, Schmitt C, Naguib NNN, Nour-Eldin NA, Eichler K, Beeres M, Vogl TJ. Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study. BMC Cancer 2018;18:188. [PMID: 29444653 DOI: 10.1186/s12885-018-4099-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
4 Cao Y, Ding Y, Zhang L, Shi G, Sang X, Ni C. Preparation of surface-modified, micrometer-sized carboxymethyl chitosan drug-loaded microspheres. J Appl Polym Sci 2018;135:45731. [DOI: 10.1002/app.45731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 de Baere T, Tselikas L, Deschamps F, Boige V, Ducreux M, Hollebecque A. Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes? Hepat Oncol 2016;3:109-18. [PMID: 30191032 DOI: 10.2217/hep-2015-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]